Two low level impurities in zoxazolyl)ethyl]-5-ethyl-6-methyl-2(1H)-py
ridinone drug substance (L-696,229) have been isolated by a combinatio
n of preparative HPLC, solid-phase extraction and liquid-liquid extrac
tion. They were identified as )ethyl]-5-ethyl-6-(2-phenylethyl)-2(1H)-
pyridinone (I) and 2-(2-benzoxazolyl)ethyl]-5-ethyl-2(1H)-pyridinone]
(II) by mass spectrometry and by their C-13 and H-1-NMR spectra.